Target intelligence / Profile preview

Thioglucoside glucohydrolase (Myrosinase) (MYR)

Target
MYR
Molecular classification
Enzyme, Glycoside hydrolase, Thioglucosidase
01

Overview

Thioglucoside glucohydrolase, commonly known as myrosinase, is a specialized family of enzymes primarily found in cruciferous vegetables like broccoli, mustard, and cabbage, as well as in certain gut microbiota. It is the only known enzyme in nature capable of cleaving the thio-linked glucose bonds found in glucosinolates, a process that serves as a chemical defense mechanism in plants known as the "mustard oil bomb." In the context of human health and pharmacology, myrosinase is a critical therapeutic target because it converts inert dietary precursors like glucoraphanin into highly bioactive isothiocyanates, such as sulforaphane. These resulting compounds are potent chemopreventive agents that exert anti-cancer and anti-inflammatory effects by inducing Phase II detoxification enzymes via the Nrf2 pathway and modulating epigenetic markers through HDAC inhibition. Although not endogenously produced by human cells, myrosinase is utilized in enzyme-prodrug therapies and functional food development to maximize the bioavailability of health-promoting metabolites. Its activity is highly dependent on environmental factors such as pH and the presence of cofactors like ascorbic acid, which can significantly influence the ratio of beneficial isothiocyanates to potentially toxic nitriles produced during hydrolysis.

Other names
SinigrinaseSinigraseThioglucosidaseGlucosinolasebeta-thioglucosidaseGlucosinolate glucohydrolase
02

Mechanism of action

Myrosinase catalyzes the hydrolysis of the thioglucosidic bond in glucosinolates to produce glucose and an unstable aglycone, which spontaneously rearranges into bioactive isothiocyanates that activate the Nrf2 antioxidant pathway and inhibit histone deacetylases (HDACs).

03

Biological functions

Hydrolysis of glucosinolatesPlant defense responseProduction of bioactive isothiocyanatesXenobiotic metabolism
04

Disease associations

CancerInflammationType 2 diabetesNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

Goitrogenic effects (interference with iodine uptake)Potential toxicity of nitrile byproductsHeat sensitivity leading to enzyme inactivationGastrointestinal distress at high doses
06

Interacting drugs

Glucoraphanin

6 more in the full profile.

07

Biomarkers

Sulforaphane-N-acetylcysteine (urinary metabolite)NAD(P)H quinone dehydrogenase 1 (NQO1) inductionGlutathione S-transferase (GST) activityHistone acetylation levels

Beyond the preview

Go deeper on Thioglucoside glucohydrolase (Myrosinase) (MYR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thioglucoside glucohydrolase (Myrosinase) (MYR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call